NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

PR legalities if data lock has been reached? I haven't been following the board lately. I am sure the subject has been discussed. Very interested in hearing the various views on this topic.

It would appear to me that they have now reached official trial maturity / data-lock / un-blinding / the primary endpoint. Of course that is not a certainty but the smell of such is all over the place.

If so... what are their PR legal responsibilities as a public company? I know they can't say wrong things... and maybe that means they can't say anything until they understand the data? Given the primary measure of efficacy was to be progression, and progression is a little debatable (though whether it is debatable is debatable) maybe they have to examine the data for quite a while to be sure what to say about progression, even if ignoring subgroups. Regarding survival, however, it would seem they would have to have a PR very soon, unless it being secondary puts it so far in the background that these laws don't apply. They could always give the survival results, even if bad, and say that subgroups are being analyzed to appease Matthew McConaughey, flipper, sentiment, cherry tree, etc.. and myself.